Peter MacPherson1, David G Lalloo2, Emily L Webb3, Hendramoorthy Maheswaran4, Augustine T Choko5, Simon D Makombe6, Anthony E Butterworth7, Joep J van Oosterhout8, Nicola Desmond1, Deus Thindwa5, Stephen Bertel Squire2, Richard J Hayes3, Elizabeth L Corbett9. 1. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom2TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. 2. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom. 3. MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom. 4. TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi4Division of Health Sciences, Warwick Medical School, University of Warwick, Warwick, United Kingdom. 5. TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. 6. HIV Department, Ministry of Health, Lilongwe, Malawi. 7. Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom. 8. Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi8Dignitas International, Zomba, Malawi. 9. TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi6Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Abstract
IMPORTANCE: Self-testing for HIV infection may contribute to early diagnosis of HIV, but without necessarily increasing antiretroviral therapy (ART) initiation. OBJECTIVE: To investigate whether offering optional home initiation of HIV care after HIV self-testing might increase demand for ART initiation, compared with HIV self-testing accompanied by facility-based services only. DESIGN, SETTING, AND PARTICIPANTS: Cluster randomized trial conducted in Blantyre, Malawi, between January 30 and November 5, 2012, using restricted 1:1 randomization of 14 community health worker catchment areas. Participants were all adult (≥16 years) residents (n = 16,660) who received access to home HIV self-testing through resident volunteers. This was a second-stage randomization of clusters allocated to the HIV self-testing group of a parent trial. INTERVENTIONS: Clusters were randomly allocated to facility-based care or optional home initiation of HIV care (including 2 weeks of ART if eligible) for participants reporting positive HIV self-test results. MAIN OUTCOMES AND MEASURES: The preplanned primary outcome compared between groups the proportion of all adult residents who initiated ART within the first 6 months of HIV self-testing availability. Secondary outcomes were uptake of HIV self-testing, reporting of positive HIV self-test results, and rates of loss from ART at 6 months. RESULTS: A significantly greater proportion of adults in the home group initiated ART (181/8194, 2.2%) compared with the facility group (63/8466, 0.7%; risk ratio [RR], 2.94, 95% CI, 2.10-4.12; P < .001). Uptake of HIV self-testing was high in both the home (5287/8194, 64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23; 95% CI, 0.96-1.58; P = .10). Significantly more adults reported positive HIV self-test results in the home group (490/8194 [6.0%] vs the facility group, 278/8466 [3.3%]; RR, 1.86; 95% CI, 1.16-2.97; P = .006). After 6 months, 52 of 181 ART initiators (28.7%) and 15 of 63 ART initiators (23.8%) in the home and facility groups, respectively, were lost from ART (adjusted incidence rate ratio, 1.18; 95% CI, 0.62-2.25, P = .57). CONCLUSIONS AND RELEVANCE: Among Malawian adults offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating ART. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01414413.
IMPORTANCE: Self-testing for HIV infection may contribute to early diagnosis of HIV, but without necessarily increasing antiretroviral therapy (ART) initiation. OBJECTIVE: To investigate whether offering optional home initiation of HIV care after HIV self-testing might increase demand for ART initiation, compared with HIV self-testing accompanied by facility-based services only. DESIGN, SETTING, AND PARTICIPANTS: Cluster randomized trial conducted in Blantyre, Malawi, between January 30 and November 5, 2012, using restricted 1:1 randomization of 14 community health worker catchment areas. Participants were all adult (≥16 years) residents (n = 16,660) who received access to home HIV self-testing through resident volunteers. This was a second-stage randomization of clusters allocated to the HIV self-testing group of a parent trial. INTERVENTIONS: Clusters were randomly allocated to facility-based care or optional home initiation of HIV care (including 2 weeks of ART if eligible) for participants reporting positive HIV self-test results. MAIN OUTCOMES AND MEASURES: The preplanned primary outcome compared between groups the proportion of all adult residents who initiated ART within the first 6 months of HIV self-testing availability. Secondary outcomes were uptake of HIV self-testing, reporting of positive HIV self-test results, and rates of loss from ART at 6 months. RESULTS: A significantly greater proportion of adults in the home group initiated ART (181/8194, 2.2%) compared with the facility group (63/8466, 0.7%; risk ratio [RR], 2.94, 95% CI, 2.10-4.12; P < .001). Uptake of HIV self-testing was high in both the home (5287/8194, 64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23; 95% CI, 0.96-1.58; P = .10). Significantly more adults reported positive HIV self-test results in the home group (490/8194 [6.0%] vs the facility group, 278/8466 [3.3%]; RR, 1.86; 95% CI, 1.16-2.97; P = .006). After 6 months, 52 of 181 ART initiators (28.7%) and 15 of 63 ART initiators (23.8%) in the home and facility groups, respectively, were lost from ART (adjusted incidence rate ratio, 1.18; 95% CI, 0.62-2.25, P = .57). CONCLUSIONS AND RELEVANCE: Among Malawian adults offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating ART. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01414413.
Authors: Nancy R Reynolds; Junfeng Sun; Haikady N Nagaraja; Allen L Gifford; Albert W Wu; Margaret A Chesney Journal: J Acquir Immune Defic Syndr Date: 2007-12-01 Impact factor: 3.731
Authors: Nicolas A Menzies; Andres A Berruti; Richard Berzon; Scott Filler; Robert Ferris; Tedd V Ellerbrock; John M Blandford Journal: AIDS Date: 2011-09-10 Impact factor: 4.177
Authors: Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens Journal: PLoS Med Date: 2009-12-01 Impact factor: 11.069
Authors: Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth Journal: Lancet Date: 2009-11-24 Impact factor: 79.321
Authors: Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole Journal: Lancet Date: 2009-04-08 Impact factor: 79.321
Authors: Amitabh B Suthar; Nathan Ford; Pamela J Bachanas; Vincent J Wong; Jay S Rajan; Alex K Saltzman; Olawale Ajose; Ade O Fakoya; Reuben M Granich; Eyerusalem K Negussie; Rachel C Baggaley Journal: PLoS Med Date: 2013-08-13 Impact factor: 11.069
Authors: Larry W Chang; Gertrude Nakigozi; Veena G Billioux; Ronald H Gray; David Serwadda; Thomas C Quinn; Maria J Wawer; Robert C Bollinger; Steven J Reynolds Journal: AIDS Behav Date: 2015-10
Authors: Kadija M Tahlil; Jason J Ong; Nora E Rosenberg; Weiming Tang; Donaldson F Conserve; Susan Nkengasong; Kathryn E Muessig; Juliet Iwelunmor; Oliver Ezechi; Titi Gbaja-Biamila; Sani H Aliyu; Chisom Obiezu-Umeh; Bill Kapogiannis; Joseph D Tucker Journal: AIDS Patient Care STDS Date: 2020-04 Impact factor: 5.078
Authors: Robin J MacGowan; Pollyanna R Chavez; Craig B Borkowf; S Michele Owen; David W Purcell; Jonathan H Mermin; Patrick S Sullivan Journal: JAMA Intern Med Date: 2020-01-01 Impact factor: 21.873
Authors: Ruanne V Barnabas; Heidi van Rooyen; Elioda Tumwesigye; Justin Brantley; Jared M Baeten; Alastair van Heerden; Bosco Turyamureeba; Philip Joseph; Meighan Krows; Katherine K Thomas; Torin T Schaafsma; James P Hughes; Connie Celum Journal: Lancet HIV Date: 2016-03-10 Impact factor: 12.767
Authors: Pablo F Belaunzarán-Zamudio; Yanink N Caro-Vega; Bryan E Shepherd; Peter F Rebeiro; Brenda E Crabtree-Ramírez; Claudia P Cortes; Beatriz Grinsztejn; Eduardo Gotuzzo; Fernando Mejia; Denis Padgett; Jean W Pape; Vanessa Rouzier; Valdilea Veloso; Sandra Wagner Cardoso; Catherine C McGowan; Juan G Sierra-Madero Journal: Am J Epidemiol Date: 2020-06-01 Impact factor: 4.897
Authors: Adam R Aluisio; Rachel K Lim; Oliver Y Tang; Janet Sugut; John Kinuthia; Rose Bosire; Kate M Guthrie; David A Katz; Carey Farquhar; Michael J Mello Journal: Acad Emerg Med Date: 2021-07-21 Impact factor: 3.451
Authors: Marc d'Elbée; Pitchaya P Indravudh; Lawrence Mwenge; Moses M Kumwenda; Musonda Simwinga; Augustine T Choko; Bernadette Hensen; Melissa Neuman; Jason J Ong; Euphemia L Sibanda; Cheryl C Johnson; Karin Hatzold; Frances M Cowan; Helen Ayles; Elizabeth L Corbett; Fern Terris-Prestholt Journal: AIDS Date: 2018-09-10 Impact factor: 4.177